Mikhael Neveen L, Seif H Gendi Myriam Abo, Hassab Hoda, Megahed Elshaymaa A
Department of Clinical & Chemical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Department of Pediatrics Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Int J Hematol Oncol. 2019 Aug 12;8(3):IJH22. doi: 10.2217/ijh-2019-0008.
Acute lymphoblastic leukemia (ALL) is a very common pediatric malignancy with high survival rates. The course of treatment is modified according to the occurrence of central nervous system (CNS) disease. To relate serum and cerebrospinal fluid levels of five biomarkers (matrix metalloprotienase 9, CCL-2, sVCAM-1, IFN-γ and inducible protein 10) at diagnosis to the development of CNS infiltration. The present study was carried on 64 children with ALL and 20 controls. Multiplexed cytokines were measured by Luminex technology (Matrix metalloprotienase 9, CCL-2, sVCAM-1, IFN-γ and inducible protein 10). Significantly higher sMMP-9 and lower sCCL2 were found in patients who developed CNS leukemia. Serum multiplexed parameters at diagnosis of childhood ALL may predict of development of CNS leukemia.
急性淋巴细胞白血病(ALL)是一种非常常见的儿童恶性肿瘤,生存率较高。治疗过程会根据中枢神经系统(CNS)疾病的发生情况进行调整。为了将诊断时五种生物标志物(基质金属蛋白酶9、CCL-2、可溶性血管细胞黏附分子-1、干扰素-γ和诱导蛋白10)的血清和脑脊液水平与CNS浸润的发展相关联。本研究对64例ALL患儿和20例对照进行。采用Luminex技术检测多种细胞因子(基质金属蛋白酶9、CCL-2、可溶性血管细胞黏附分子-1、干扰素-γ和诱导蛋白10)。发生CNS白血病的患者中可溶性基质金属蛋白酶-9显著升高,可溶性CCL2降低。儿童ALL诊断时的血清多项参数可能预测CNS白血病的发生。